These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38977535)

  • 1. Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.
    Elsman EBM; Mokkink LB; Terwee CB; Beaton D; Gagnier JJ; Tricco AC; Baba A; Butcher NJ; Smith M; Hofstetter C; Aiyegbusi OL; Berardi A; Farmer J; Haywood KL; Krause KR; Markham S; Mayo-Wilson E; Mehdipour A; Ricketts J; Szatmari P; Touma Z; Moher D; Offringa M
    J Patient Rep Outcomes; 2024 Jul; 8(1):64. PubMed ID: 38977535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.
    Elsman EBM; Mokkink LB; Terwee CB; Beaton D; Gagnier JJ; Tricco AC; Baba A; Butcher NJ; Smith M; Hofstetter C; Aiyegbusi OL; Berardi A; Farmer J; Haywood KL; Krause KR; Markham S; Mayo-Wilson E; Mehdipour A; Ricketts J; Szatmari P; Touma Z; Moher D; Offringa M
    Health Qual Life Outcomes; 2024 Jul; 22(1):48. PubMed ID: 38978063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.
    Elsman EBM; Mokkink LB; Terwee CB; Beaton D; Gagnier JJ; Tricco AC; Baba A; Butcher NJ; Smith M; Hofstetter C; Aiyegbusi OL; Berardi A; Farmer J; Haywood KL; Krause KR; Markham S; Mayo-Wilson E; Mehdipour A; Ricketts J; Szatmari P; Touma Z; Moher D; Offringa M
    Qual Life Res; 2024 Aug; 33(8):2029-2046. PubMed ID: 38980635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.
    Elsman EBM; Mokkink LB; Terwee CB; Beaton D; Gagnier JJ; Tricco AC; Baba A; Butcher NJ; Smith M; Hofstetter C; Lee Aiyegbusi O; Berardi A; Farmer J; Haywood KL; Krause KR; Markham S; Mayo-Wilson E; Mehdipour A; Ricketts J; Szatmari P; Touma Z; Moher D; Offringa M
    J Clin Epidemiol; 2024 Sep; 173():111422. PubMed ID: 38849061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol for developing, piloting and disseminating the PRISMA-COSMIN guideline: a new reporting guideline for systematic reviews of outcome measurement instruments.
    Elsman EBM; Butcher NJ; Mokkink LB; Terwee CB; Tricco A; Gagnier JJ; Aiyegbusi OL; Barnett C; Smith M; Moher D; Offringa M
    Syst Rev; 2022 Jun; 11(1):121. PubMed ID: 35698213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.
    McInnes MDF; Moher D; Thombs BD; McGrath TA; Bossuyt PM; ; Clifford T; Cohen JF; Deeks JJ; Gatsonis C; Hooft L; Hunt HA; Hyde CJ; Korevaar DA; Leeflang MMG; Macaskill P; Reitsma JB; Rodin R; Rutjes AWS; Salameh JP; Stevens A; Takwoingi Y; Tonelli M; Weeks L; Whiting P; Willis BH
    JAMA; 2018 Jan; 319(4):388-396. PubMed ID: 29362800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A blueprint for patient and public involvement in the development of a reporting guideline for systematic reviews of outcome measurement instruments: PRISMA-COSMIN for OMIs 2024.
    Elsman EBM; Smith M; Hofstetter C; Gavin F; Jobson E; Markham S; Ricketts J; Baba A; Butcher NJ; Offringa M
    Res Involv Engagem; 2024 Mar; 10(1):33. PubMed ID: 38515153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement.
    Gates M; Gates A; Pieper D; Fernandes RM; Tricco AC; Moher D; Brennan SE; Li T; Pollock M; Lunny C; Sepúlveda D; McKenzie JE; Scott SD; Robinson KA; Matthias K; Bougioukas KI; Fusar-Poli P; Whiting P; Moss SJ; Hartling L
    BMJ; 2022 Aug; 378():e070849. PubMed ID: 35944924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring communication as a core outcome in aphasia trials: Results of the ROMA-2 international core outcome set development meeting.
    Wallace SJ; Worrall L; Rose TA; Alyahya RSW; Babbitt E; Beeke S; de Beer C; Bose A; Bowen A; Brady MC; Breitenstein C; Bruehl S; Bryant L; Cheng BBY; Cherney LR; Conroy P; Copland DA; Croteau C; Cruice M; Dipper L; Hilari K; Howe T; Kelly H; Kiran S; Laska AC; Marshall J; Murray LL; Patterson J; Pearl G; Quinting J; Rochon E; Rose ML; Rubi-Fessen I; Sage K; Simmons-Mackie N; Visch-Brink E; Volkmer A; Webster J; Whitworth A; Dorze GL
    Int J Lang Commun Disord; 2023; 58(4):1017-1028. PubMed ID: 36583427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRISMA-Children (C) and PRISMA-Protocol for Children (P-C) Extensions: a study protocol for the development of guidelines for the conduct and reporting of systematic reviews and meta-analyses of newborn and child health research.
    Kapadia MZ; Askie L; Hartling L; Contopoulos-Ioannidis D; Bhutta ZA; Soll R; Moher D; Offringa M
    BMJ Open; 2016 Apr; 6(4):e010270. PubMed ID: 27091820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporting items for systematic reviews and meta-analyses of acupuncture: the PRISMA for acupuncture checklist.
    Wang X; Chen Y; Liu Y; Yao L; Estill J; Bian Z; Wu T; Shang H; Lee MS; Wei D; Tian J; Ma B; Wang Y; Tian G; Yang K
    BMC Complement Altern Med; 2019 Aug; 19(1):208. PubMed ID: 31405367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for reporting pediatric and child health clinical trial protocols and reports: study protocol for SPIRIT-Children and CONSORT-Children.
    Baba A; Smith M; Potter BK; Chan AW; Moher D; Offringa M
    Trials; 2024 Jan; 25(1):96. PubMed ID: 38287439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRISMA harms checklist: improving harms reporting in systematic reviews.
    Zorzela L; Loke YK; Ioannidis JP; Golder S; Santaguida P; Altman DG; Moher D; Vohra S;
    BMJ; 2016 Feb; 352():i157. PubMed ID: 26830668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies: The AGReMA Statement.
    Lee H; Cashin AG; Lamb SE; Hopewell S; Vansteelandt S; VanderWeele TJ; MacKinnon DP; Mansell G; Collins GS; Golub RM; McAuley JH; ; Localio AR; van Amelsvoort L; Guallar E; Rijnhart J; Goldsmith K; Fairchild AJ; Lewis CC; Kamper SJ; Williams CM; Henschke N
    JAMA; 2021 Sep; 326(11):1045-1056. PubMed ID: 34546296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension.
    Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
    JAMA; 2022 Dec; 328(23):2345-2356. PubMed ID: 36512367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.
    Stewart LA; Clarke M; Rovers M; Riley RD; Simmonds M; Stewart G; Tierney JF;
    JAMA; 2015 Apr; 313(16):1657-65. PubMed ID: 25919529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.
    Tricco AC; Lillie E; Zarin W; O'Brien KK; Colquhoun H; Levac D; Moher D; Peters MDJ; Horsley T; Weeks L; Hempel S; Akl EA; Chang C; McGowan J; Stewart L; Hartling L; Aldcroft A; Wilson MG; Garritty C; Lewin S; Godfrey CM; Macdonald MT; Langlois EV; Soares-Weiser K; Moriarty J; Clifford T; Tunçalp Ö; Straus SE
    Ann Intern Med; 2018 Oct; 169(7):467-473. PubMed ID: 30178033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
    Dimairo M; Pallmann P; Wason J; Todd S; Jaki T; Julious SA; Mander AP; Weir CJ; Koenig F; Walton MK; Nicholl JP; Coates E; Biggs K; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG;
    Trials; 2020 Jun; 21(1):528. PubMed ID: 32546273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential items for reporting of scaling studies of health interventions (SUCCEED): protocol for a systematic review and Delphi process.
    Gogovor A; Zomahoun HTV; Ben Charif A; McLean RKD; Moher D; Milat A; Wolfenden L; Prévost K; Aubin E; Rochon P; Ekanmian G; Sawadogo J; Rheault N; Légaré F
    Syst Rev; 2020 Jan; 9(1):11. PubMed ID: 31926555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.